Work Here?
Industries
Biotechnology
Healthcare
Company Size
10,001+
Company Stage
IPO
Headquarters
Cambridge, United Kingdom
Founded
1913
AstraZeneca focuses on discovering, developing, and selling prescription medicines. The company specializes in three main areas: Oncology, which deals with cancer treatment; Cardiovascular, Renal & Metabolism, which addresses heart, kidney, and metabolic diseases; and Respiratory & Immunology, which targets lung and immune system diseases. Their products are developed through extensive research and development, followed by clinical trials and regulatory approvals before reaching the market. AstraZeneca distinguishes itself from competitors by investing heavily in scientific research and forming strategic partnerships to enhance drug discovery. Their goal is to advance healthcare by creating effective treatments for serious diseases and collaborating with other organizations to improve their research capabilities.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$3509.6M
Above
Industry Average
Funded Over
2 Rounds
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
Paid Vacation
Paid Holidays
Flexible Work Hours
AstraZeneca unveils breakthrough data on vaccines and antibody therapies for infections.
AstraZeneca invested €365 million in expanding its production lines in Dunkirk.
04 April 2025 Imfinzi-based perioperative regimen approved in the EU for resectable non-small cell lung cancer Approval based on AEGEAN Phase III trial results which showed a 32% reduction in the risk of recurrence, progression or death vs. neoadjuvant chemotherapy alone AstraZeneca's Imfinzi (durvalumab) in combination with chemotherapy has been approved in the European Union (EU) for the treatment of adults with resectable non-small cell lung cancer (NSCLC) at high risk of recurrence and no epidermal growth factor receptor (EGFR) mutations or anaplastic lymphoma kinase (ALK)
Enhertu approved in EU in post-ET breast cancer
Imfinzi approved in the US for bladder cancer
Wilmington, DE, USA
$108.5k - $162.7k/yr
Gaithersburg, MD, USA
Find jobs on Simplify and start your career today
Data & Analytics
44 Open Roles
Software Engineering
26 Open Roles
IT & Security
19 Open Roles
DevOps & Infrastructure
18 Open Roles
AI & Machine Learning
17 Open Roles
QA & Testing
8 Open Roles
Process Engineering
6 Open Roles
Mechanical Engineering
6 Open Roles
Engineering Management
4 Open Roles
Sales & Solution Engineering
1 Open Roles
Hardware Engineering
1 Open Roles
Architecture & Civil Engineering
1 Open Roles
Operations & Logistics
25 Open Roles
Business & Strategy
22 Open Roles
Sales & Account Management
19 Open Roles
Product
9 Open Roles
Consulting
9 Open Roles
Growth & Marketing
6 Open Roles
Finance & Banking
3 Open Roles
Accounting
1 Open Roles
Training
3 Open Roles
Discover companies similar to AstraZeneca
Industries
Biotechnology
Healthcare
Company Size
10,001+
Company Stage
IPO
Headquarters
Cambridge, United Kingdom
Founded
1913
Buxton, UK
Wilmington, DE, USA
$108.5k - $162.7k/yr
Gaithersburg, MD, USA
Find jobs on Simplify and start your career today
Data & Analytics
44 Open Roles
Software Engineering
26 Open Roles
IT & Security
19 Open Roles
DevOps & Infrastructure
18 Open Roles
AI & Machine Learning
17 Open Roles
QA & Testing
8 Open Roles
Process Engineering
6 Open Roles
Mechanical Engineering
6 Open Roles
Engineering Management
4 Open Roles
Sales & Solution Engineering
1 Open Roles
Hardware Engineering
1 Open Roles
Architecture & Civil Engineering
1 Open Roles
Operations & Logistics
25 Open Roles
Business & Strategy
22 Open Roles
Sales & Account Management
19 Open Roles
Product
9 Open Roles
Consulting
9 Open Roles
Growth & Marketing
6 Open Roles
Finance & Banking
3 Open Roles
Accounting
1 Open Roles
Training
3 Open Roles
Discover companies similar to AstraZeneca